203 related articles for article (PubMed ID: 21415100)
1. SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell.
Jia X; Li X; Xu Y; Zhang S; Mou W; Liu Y; Liu Y; Lv D; Liu CH; Tan X; Xiang R; Li N
J Mol Cell Biol; 2011 Aug; 3(4):230-8. PubMed ID: 21415100
[TBL] [Abstract][Full Text] [Related]
2. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
Rybak AP; Tang D
Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
[TBL] [Abstract][Full Text] [Related]
3. SOX2 function and Hedgehog signaling pathway are co-conspirators in promoting androgen independent prostate cancer.
Kar S; Sengupta D; Deb M; Pradhan N; Patra SK
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):253-265. PubMed ID: 27816521
[TBL] [Abstract][Full Text] [Related]
4. Sox2 targets cyclinE, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis.
Lin F; Lin P; Zhao D; Chen Y; Xiao L; Qin W; Li D; Chen H; Zhao B; Zou H; Zheng X; Yu X
Cell Prolif; 2012 Jun; 45(3):207-16. PubMed ID: 22469032
[TBL] [Abstract][Full Text] [Related]
5. SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis.
Russo MV; Esposito S; Tupone MG; Manzoli L; Airoldi I; Pompa P; Cindolo L; Schips L; Sorrentino C; Di Carlo E
Oncotarget; 2016 Mar; 7(11):12372-85. PubMed ID: 26540632
[TBL] [Abstract][Full Text] [Related]
6. Sox2 expression involvement in the oncogenicity and radiochemoresistance of oral cancer stem cells.
Chou MY; Hu FW; Yu CH; Yu CC
Oral Oncol; 2015 Jan; 51(1):31-9. PubMed ID: 25456004
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma.
Fang WT; Fan CC; Li SM; Jang TH; Lin HP; Shih NY; Chen CH; Wang TY; Huang SF; Lee AY; Liu YL; Tsai FY; Huang CT; Yang SJ; Yen LJ; Chuu CP; Chen CY; Hsiung CA; Chang JY; Wang LH; Chang IS; Jiang SS
Int J Cancer; 2014 Aug; 135(4):809-19. PubMed ID: 24477565
[TBL] [Abstract][Full Text] [Related]
8. Cancer-driven IgG promotes the development of prostate cancer though the SOX2-CIgG pathway.
Qin C; Sheng Z; Huang X; Tang J; Liu Y; Xu T; Qiu X
Prostate; 2020 Sep; 80(13):1134-1144. PubMed ID: 32628304
[TBL] [Abstract][Full Text] [Related]
9. The emerging role of SOX2 in cell proliferation and survival and its crosstalk with oncogenic signaling in lung cancer.
Chou YT; Lee CC; Hsiao SH; Lin SE; Lin SC; Chung CH; Chung CH; Kao YR; Wang YH; Chen CT; Wei YH; Wu CW
Stem Cells; 2013 Dec; 31(12):2607-19. PubMed ID: 23940081
[TBL] [Abstract][Full Text] [Related]
10. LIN28B promotes the development of neuroendocrine prostate cancer.
Lovnicki J; Gan Y; Feng T; Li Y; Xie N; Ho CH; Lee AR; Chen X; Nappi L; Han B; Fazli L; Huang J; Gleave ME; Dong X
J Clin Invest; 2020 Oct; 130(10):5338-5348. PubMed ID: 32634132
[TBL] [Abstract][Full Text] [Related]
11. SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT/β-catenin signal network.
Li X; Xu Y; Chen Y; Chen S; Jia X; Sun T; Liu Y; Li X; Xiang R; Li N
Cancer Lett; 2013 Aug; 336(2):379-89. PubMed ID: 23545177
[TBL] [Abstract][Full Text] [Related]
12. Sox2 is involved in paclitaxel resistance of the prostate cancer cell line PC-3 via the PI3K/Akt pathway.
Li D; Zhao LN; Zheng XL; Lin P; Lin F; Li Y; Zou HF; Cui RJ; Chen H; Yu XG
Mol Med Rep; 2014 Dec; 10(6):3169-76. PubMed ID: 25310235
[TBL] [Abstract][Full Text] [Related]
13. ChIP-seq and functional analysis of the SOX2 gene in colorectal cancers.
Fang X; Yu W; Li L; Shao J; Zhao N; Chen Q; Ye Z; Lin SC; Zheng S; Lin B
OMICS; 2010 Aug; 14(4):369-84. PubMed ID: 20726797
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Chiu FL; Lin JK
Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
[TBL] [Abstract][Full Text] [Related]
15. Sox2-dependent inhibition of p21 is associated with poor prognosis of endometrial cancer.
Yamawaki K; Ishiguro T; Mori Y; Yoshihara K; Suda K; Tamura R; Yamaguchi M; Sekine M; Kashima K; Higuchi M; Fujii M; Okamoto K; Enomoto T
Cancer Sci; 2017 Apr; 108(4):632-640. PubMed ID: 28188685
[TBL] [Abstract][Full Text] [Related]
16. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
[TBL] [Abstract][Full Text] [Related]
17. Remodeling of channel-forming ORAI proteins determines an oncogenic switch in prostate cancer.
Dubois C; Vanden Abeele F; Lehen'kyi V; Gkika D; Guarmit B; Lepage G; Slomianny C; Borowiec AS; Bidaux G; Benahmed M; Shuba Y; Prevarskaya N
Cancer Cell; 2014 Jul; 26(1):19-32. PubMed ID: 24954132
[TBL] [Abstract][Full Text] [Related]
18. SOX2 promotes tumorigenicity and inhibits the differentiation of I-type neuroblastoma cells.
Yang S; Zheng J; Xiao X; Xu T; Tang W; Zhu H; Yang L; Zheng S; Dong K; Zhou G; Wang Y
Int J Oncol; 2015 Jan; 46(1):317-23. PubMed ID: 25333857
[TBL] [Abstract][Full Text] [Related]
19. Sex determining region Y-box 2 inhibits the proliferation of colorectal adenocarcinoma cells through the mTOR signaling pathway.
Liu H; Du L; Wen Z; Yang Y; Li J; Dong Z; Zheng G; Wang L; Zhang X; Wang C
Int J Mol Med; 2013 Jul; 32(1):59-66. PubMed ID: 23599173
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.
Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH
Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
